7/12/2025​​​​​​​Recent Official and Executive Moves

7/12/2025China's First 9-Valent HPV Vaccine Launches at 60% Discount, Undercutt...

7/12/2025Flamma Opens New cGMP Plant in Dalian

7/11/2025Vice Premier Urges Stronger Focus on Basic Pharmaceutical Research an...

7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...

7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...

7/11/2025Biocytogen Strengthens Ties with BeOne Thru Expanded Antibody Licensin...

7/11/2025TandemAI and Perpetual Medicine Announce Strategic Merger

7/11/2025Haleon Secures Full Ownership of Tianjin Sino‑American JV

7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...

7/11/2025China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...

More>>

7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...

7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)

7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...

6/27/2025Analyzing Key Trends in China's Patent-Linkage System and Their Impact...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...

More>>